Really, it is emerging a growing number of cases in which the screening parameters are not concordant, also as most of the 2000 CFTR variants described so far in patients with CF or CFTR-RD [5] have unclear or variable phenotypic consequences and so ST may result intermediate (i.e., between 30 and 59 mmol/L). This evidence concerns the gene CFTR and cystic fibrosis.